Precision BioSciences gets FDA orphan drug designations for DMD treatment
Go back to Precision BioSciences gets FDA orphan drug designations for DMD treatment| (NASDAQ: DTIL) | Delayed: 8.49 -0.06 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.55 | 52 Week High | $ | |||
| Open | $8.58 | 52 Week Low | $ | |||
| Day High | $8.66 | P/E | N/A | |||
| Day Low | $8.33 | EPS | $ | |||
| Volume | 263,209 | |||||

